drugset / Trial / NCT00003703

Chemotherapy in Treating Patients With Advanced Solid Tumors

NCT00003703 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of chemotherapy using sarCNU in patients who have advanced solid tumors.

Timeline

Start
1999-01
Primary completion
—
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject SarCNU Small molecule 30 mg/m2 Oral
Subject SarCNU Small molecule 1075 mg/m2 Oral